019736 S470 M1 1571

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

3

Download PDF ↗ Live URL (may be dead)

Document text

BioNTech SE 08/30/2021
An der Goldgrube 12
Mainz N/A
Germany 55131214-918-5262
COVID-19 Vaccine (BNT162, PF-07302048) 019736
Active immunization to prevent COVID-19 caused by 
SARS-CoV-2
Phase 4
BB-IND 013812, BB-IND 013278, BLA 125549
0 4 6 9
3
FDA-CBER-2021 5683-1072534
Özlem Türeci, MD, Chief Medical Officer, BioNTech SE
Özlem Türeci, MD, Chief Medical Officer, BioNTech SE 
Amit Patel, Director, Global Regulatory Affairs - Vaccines
214-918-5262 845-474-3500
235 East 42nd Street
New York NY
United States of America [email protected]
08/29/2021
United States of America
Amit PatelDigitally signed by Amit Patel 
Reason: I attest to the accuracy and 
integrity of this document 
Date: 20210829 09:29:40 -05'00'
3
FDA-CBER-2021-5683-1072535
3
FDA-CBER-2021-5683-1072536